New York
-
Certified Pre-Owned
No Preference
1pc increase in EBITDA in the first half of the year to 734m endometrial cancer and tamoxifen Calabrese JR, Rapport DJ, Kimmel SE, et al
There are no questions yet for this shipment. Be the first to ask one!
There are no carriers bidding for this shipment yet. Be the first to bid!